Cyclacel Pharmaceutical Inc (CYCC)

[aaron_03]

Something brewing

What a pop this morning. I think there's something cooking with Cyclacel. Obviously, we know about the pre-clinical data that was introduced at the AACR meeting last week. Unfortunately, the stock was affected by that spare Adam Feuerstein's tweet and podcast. But it has rebounded nicely. Cyclacel's pipeline is fairly strong. Also, I don't think it's a coincidence that Kevin Tang has invested heavily in this company. I wouldn't be surprised if it's revealed in the next few days that he's purchased even more shares in the company. We shall see.